Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Effects of genetic polymorphisms on the sulfation of doxorubicin by human SULT1C4 allozymes

The Journal of Biochemistry(2021)10.1093/jb/mvab055Source: DataRank Database

Effects of genetic polymorphisms on the sulfation of doxorubicin by human SULT1C4 allozymes is a research paper published in The Journal of Biochemistry (2021). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

refsnp pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.49)OA: greenTopics (55)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Mohammed I. Rasool,Ahsan F. Bairam ORCID,Eid Alatwi ORCID,Fatemah A. Alherz ORCID,Maryam S. Abunnaja

Live enrichment

PubMed:33950190 PMC:PMC8510289 OpenAlex:https://openalex.org/W3157159682

National Institutes of Health

Grant: # R03HD071146

NICHD NIH HHS

Grant: R03 HD071146

National Institutes of Health

Grant: 1R03HD071146-01A1

Ontogeny of the Phase II cytosolic sulfotransferases and adverse drug reactions

FWCI

0.49

Citation Percentile

0.5%

Citation Trend

2022

2023

2024

greenLicense: OUP Standard Publication Reuse

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8510289

publisherhttp://academic.oup.com/jb/advance-article-pdf/doi/10.1093/jb/mvab055/38388822/mvab055.pdf

publisherhttps://academic.oup.com/jb/article-pdf/170/3/419/40576283/mvab055.pdf

journalhttps://doi.org/10.1093/jb/mvab055

Fields of Study

Mass Spectrometry Techniques and ApplicationsChemotherapy-induced cardiotoxicity and mitigationCancer therapeutics and mechanisms0301 basic medicine01 natural sciences0104 chemical sciences03 medical and health sciencesCytosolDoxorubicinGenotypeHumansIsoenzymesKineticsMutagenesis, Site-DirectedNitrophenolsPolymorphism, Single NucleotideSulfatesSulfotransferases

MeSH Terms

CytosolDoxorubicinGenotypeHumansIsoenzymesKineticsNitrophenolsSulfatesSulfotransferasesMutagenesis, Site-DirectedPolymorphism, Single Nucleotide

Keywords

DoxorubicinSulfotransferaseSingle-nucleotide polymorphismSulfationBiologyNonsynonymous substitutionBiochemistryEnzymeGeneGenotypeGeneticsGenomeSNPsSingle Nucleotide PolymorphismsSultCytosolic SulfotransferaseSult1c4SulfatesPolymorphism, Single NucleotideIsoenzymesNitrophenolsKineticsCytosolMutagenesis, Site-DirectedHumansSulfotransferases

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Effects of genetic polymorphisms on the sulfation of doxorubicin by human SULT1C4 allozymes

FAIR Checklist

Authors (9)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)